TY - JOUR T1 - Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy? JF - Journal of Nuclear Medicine JO - J Nucl Med SP - 1137 LP - 1144 DO - 10.2967/jnumed.119.237891 VL - 61 IS - 8 AU - Susanne Lütje AU - Georg Feldmann AU - Markus Essler AU - Peter Brossart AU - Ralph A. Bundschuh Y1 - 2020/08/01 UR - http://jnm.snmjournals.org/content/61/8/1137.abstract N2 - Immune checkpoint blockade represents a promising approach in oncology, showing antitumor activities in various cancers. However, although being generally far better tolerated than classic cytotoxic chemotherapy, this treatment, too, may be accompanied by considerable side effects and not all patients benefit equally. Therefore, careful patient selection and monitoring of the treatment response is mandatory. At present, checkpoint-specific molecular imaging is being increasingly investigated as a tool for patient selection and response evaluation. Here, an overview of the current developments in immune checkpoint imaging is provided. ER -